Addex Therapeutics Ltd (ADXN)
8.11
+0.73
(+9.89%)
USD |
NASDAQ |
Nov 21, 16:00
7.99
-0.12
(-1.48%)
After-Hours: 07:56
Addex Therapeutics Total Liabilities (Quarterly): 1.164M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 1.164M |
| March 31, 2024 | 5.219M |
| December 31, 2023 | 4.163M |
| September 30, 2023 | 2.398M |
| June 30, 2023 | 3.194M |
| March 31, 2023 | 3.528M |
| December 31, 2022 | 3.634M |
| September 30, 2022 | 4.399M |
| June 30, 2022 | 4.736M |
| March 31, 2022 | 5.119M |
| December 31, 2021 | 6.138M |
| September 30, 2021 | 5.050M |
| June 30, 2021 | 5.547M |
| March 31, 2021 | 6.556M |
| December 31, 2020 | 6.378M |
| September 30, 2020 | 4.244M |
| June 30, 2020 | 4.569M |
| March 31, 2020 | 7.389M |
| December 31, 2019 | 7.746M |
| June 30, 2019 | 5.831M |
| December 31, 2018 | 3.020M |
| June 30, 2018 | 2.603M |
| June 30, 2018 | 2.603M |
| Date | Value |
|---|---|
| December 31, 2017 | 1.766M |
| June 30, 2017 | 1.536M |
| June 30, 2017 | 1.536M |
| December 31, 2016 | 1.439M |
| June 30, 2016 | 1.450M |
| June 30, 2016 | 1.450M |
| December 31, 2015 | 1.240M |
| June 30, 2015 | 1.257M |
| June 30, 2015 | 1.257M |
| December 31, 2014 | 1.672M |
| June 30, 2014 | 2.649M |
| June 30, 2014 | 2.649M |
| December 31, 2013 | 3.216M |
| June 30, 2013 | 6.947M |
| June 30, 2013 | 6.947M |
| December 31, 2012 | 8.128M |
| June 30, 2012 | 8.976M |
| June 30, 2012 | 8.976M |
| December 31, 2011 | 12.39M |
| June 30, 2011 | 11.68M |
| December 31, 2010 | 10.56M |
| June 30, 2010 | 7.160M |
| December 31, 2009 | 10.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.164M
Minimum
Jun 2024
7.746M
Maximum
Dec 2019
4.798M
Average
4.736M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 135.61M |
| CRISPR Therapeutics AG | 316.47M |
| NLS Pharmaceutics Ltd | 10.46M |
| Molecular Partners AG | 18.34M |
| MoonLake Immunotherapeutics | 22.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 15.24M |
| Shareholders Equity (Quarterly) | 14.07M |
| Current Ratio | 4.974 |